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Abstract
IKKβ serves as a central intermediate signaling molecule in the activation of the NF-κB pathway.
However, the precise mechanism for the termination of IKKβ activity is still not fully understood.
Using a functional genomic approach, we have identified two protein serine/threonine phosphatases,
PPM1A and PPM1B, as IKKβ phosphatases. Overexpression of PPM1A or PPM1B results in
dephosphorylation of IKKβ at Ser177 and Ser181 and termination of IKKβ-induced NF-κB
activation. PPM1A and PPM1B associate with the phosphorylated form of IKKβ, and the interaction
between PPM1A/PPM1B and IKKβ is induced by TNFα in a transient fashion in the cells.
Furthermore, knockdown of PPM1A and PPM1B expression enhances TNFα-induced IKKβ
phosphorylation, NF-κB nuclear translocation and NF-κB-dependent gene expression. These data
suggest that PPM1A and PPM1B play an important role in the termination of TNFα-mediated NF-
κB activation through dephosphorylating and inactivating IKKβ.
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The NF-κB family of transcription factors plays critical roles in controlling inflammation,
immune response, and anti-apoptosic responses [1–3]. Stimulation of various cell surface
receptors, including receptors for proinflammatory cytokines such as tumor necrosis factor
(TNFα) and Interleukin-1 (IL-1β), Toll-like receptors (TLRs), antigen receptors, and G protein-
coupled receptors (GPCRs), activates NF-κB [4]. In unstimulated cells, NF-κB is sequestered
in the cytoplasm by its inhibitory proteins, which are members of the IκB family. Cell
stimulation results in phosphorylation of IκB proteins and subsequently rapid ubiquitination
and degradation through the 26S proteasome [5–7]. Degradation of the IκB proteins liberates
NF-κB and allows its translocation to the nucleus, where it controls the expression of the target
genes [8].
Phosphorylation of IκB protein is achieved by the activated IκB kinase (IKK) [9–16]. The
activation of the IKK complex composed of two catalytic subunits, IKKα and IKKβ, and a
regulatory subunit, IKKγ/NEMO, is the convergence point for many NF-κB signaling
pathways and activity of IKKs is regulated by phosphorylation [17,18]. Gene knockout studies
indicate that IKKβ is the catalytic subunit required for activation of NF-κB in response to
TNFα[19,20].
One of the critical steps for the kinase activation is the phosphorylation of the specific serine
or threonine residues within the activation loop of the protein kinase located between kinase
subdomains VII and VIII. Activation of IKKβ requires phosphorylation of the conserved
residues Ser177 and Ser181 within the kinase activation loop. Mutation of these serine residues
to alanine markedly decreases IKKβ activity, whereas replacement of these serine residues
with glutamates results in the generation of constitutively active kinases [17,18].
Although significant progress has been made on the mechanism of the IKKβ activation, it is
unclear how IKKβ activation is down-regulated in the cells and which member of the protein
serine/threonine phosphatase family dephosphorylates the conserved residues Ser177 and
Ser181 within the kinase activation loop of IKKβ. Several phosphatases including PPM1B
have been shown to be able to regulate IKKβ activity [16,18,21–23]. However, the identity of
the protein serine/threonine phosphatases that dephosphorylate IKKβ and inhibit its activity
remains to be clearly defined.
Protein serine/threonine phosphatases in the human genome are mainly composed of two
structurally distinct families: PPP and PPM/PP2C [24,25]. The PPP family, including PPP1,
PPP2/PP2A, PPP3/PP2B, PPP4, PPP5, PPP6 and PPP7, consists of a highly conserved catalytic
domain and distinct regulatory domains or subunits. The PPM family is a group of monomeric
metal-ion-dependent phosphatases including PPM1A, PPM1B, PPM1C, PPM1D/wip1,
PPM1E, PPM1F, PPM1G, PPM1H, PPM1J, PPM1L, PPM1K, PPM1M, PHLPP, PPTC7,
PPM2C.
In this report, we used a functional genomic approach to identify the IKKβ phosphatase by
screening a library of serine/threonine phosphatases whose overexpression inhibits IKKβ-
mediated NF-κB activation and dephosphorylates IKKβ at the conserved residues Ser177 and
Ser181 within the kinase activation loop. Here we present evidence that PPM1A/PP2Cα and
PPM1B/PP2Cβ function as the IKKβ phosphatases that dephosphorylate IKKβ and terminate
IKKβ-mediated NF-κB activation.
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2. Materials and methods
2.1. Cell culture and transfection
HEK 293 and HEK 293T cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), and transfected with FuGene 6
(Roche) according to the manufacturer’s recommendation. HeLa cells were cultured in Eagle’s
Minimum Essential Medium (EMEM) supplemented with 10% FBS, sodium pyruvate (1 mM)
and transfected with FuGene HD (Roche) following the manufacturer’s protocol. The above
media also contained penicillin (100 U/ml), streptomycin (100 mg/ml) and glutamine (2 mM).
2.2. Construction of Human serine/threonine phosphatase Expression Library
Human serine/threonine phosphatase clones were purchased from ATCC and Open Biosystem.
Full-length cDNA sequence for each phosphatase containing an open reading frame was
subcloned into pcDNA3.1 expression vector (Invitrogen). Mammalian PPP1CC expression
vector was kindly provided by Dr. Sergei Nekhai (Howard University, Washington DC),
PPM1D was obtained from Dr. Larry Donehower (Baylor College of Medicine, TX), and
PPP5C from Dr. Xiaofan Wang (Duke University, NC).
2.3. Expression plasmids and small hairpin RNA expression constructs
The full-length open reading frame of the wildtype human PPM1A and PPM1B were subcloned
in frame into mammalian expression vector pcDNA3.1 with an N-terminal 3Myc tag
(Invitrogen). The PPM1A (R174G) and PPM1B (R179G) mutant expression constructs were
generated by site-directed PCR mutagenesis (Stratagene) and verified by DNA sequencing.
Mammalian expression vector for HA-IKKβ was obtained from Dr. Paul Chiao (The University
of Texas MD Anderson Cancer Center, TX). The NF-κB-dependent firefly luciferase reporter
plasmid and pCMV promoter-dependent Renilla luciferase reporter plasmid were purchased
from Clontech (Mountain View, California). For bacterial expression of both PPM1A and
PPM1B proteins, cDNAs encoding the wildtype (GST-PPM1A-wt and GST-PPM1B-wt) and
phosphatase-deficient mutant version (GST-PPM1A-R174G and GST-PPM1B-R179G) of
these two proteins were subcloned into pGEX-KG vector (Invitrogen) to generate glutathione
S-transferase (GST) fusion proteins. A pSuper-retro vector (Ambion) was used to generate
shRNA plasmids for PPM1A and PPM1B. For PPM1A, the following target sequences have
been selected: 5′-AAGAGGAATGTTATTGAAGCC-3′ (shPPM1A-1), 5′-
AAGTACCTGGAATGCAGAGTA-3′ (shPPM1A-2); and for PPM1B, target sequences were
5′-AATGCAGGAAAGCCATACTGA-3′ (shPPM1B-1), 5′-
AACTTCTGGAGGAGATGCTGA-3′ (shPPM1B-2); pSuper-shRNA-control is: 5′-
CTGGCATCGGTGTGGATGA-3′. The authenticity of these plasmids was confirmed by
sequencing.
2.4. Antibodies and reagents
Antibodies against HA epitope, Myc epitope, NF-κB-p65, PCNA (PC-10) were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); anti-β-actin antibody was from Sigma-
Aldrich Co. (St. Louis, MO). Antibodies against Phospho-IKKα/β and IKKβ were from Cell
Signaling Technology, Inc. (Danvers, MA). Antibody against PPM1A was from Abcam Inc.
(Cambridge, MA), and antibody against PPM1B was from Bethyl Laboratories, Inc.
(Montgomery, TX). Recombinant human TNFα was purchased from the R & D Systems
(Minneapolis, MN). FuGene 6 and FuGene HD transfection reagents were from Roche
(Alameda, CA). Cell culture media were obtained from Invitrogen (Carlsbad, CA).
Nitrocellulose membrane was obtained from Bio-Rad (Hercules, CA).
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2.5. Luciferase reporter gene assays
The luciferase reporter gene assay was performed using a dual luciferase reporter assay system
(Promega, Madison, WI) and a Monolight 3010 luminometer (BD PharMingen, San Diego,
CA) as described previously [26]. Briefly, targeted cells were transiently cotransfected with
specific vectors and an NF-κB-dependent firefly luciferase reporter construct as well as a
Renilla luciferase control construct. Cellular extracts were prepared 36 hrs post-transfection
and the luciferase activities were determined. Relative NF-κB luciferase activity was
normalized to Renilla luciferase activity. Data are presented as the mean ± standard deviation
and are representative of three independent experiments.
2.6. Quantitative reverse transcription PCR (qRT-PCR) analyse
Total RNAs were prepared using TriZol reagent (Invitrogen) from HeLa pSuper-shRNA-
control, pSuper-shPPM1A and pSuper-shPPM1B cells. qRT-PCR was carried out by using
100 ng of total RNA. A volume of 10 μl of 2x QuantiTect SYBR Green RT-PCR Master Mix
(Qiagen), 0.2 μl QuantiTect RT Mix (Qiagen), 1 μl of 10 μM forward and reverse primers, and
6.8 μl of RNase-Free Water were added to each sample for analysis by absolute quantification.
qRT-PCR was performed in 96-well plates with the DNA Engine Opticon™ System (MJ
Research). The mRNA levels of target genes in the samples were normalized against β-actin.
Each target gene was measured in triplicate. The primers were designed by using the Primer3.0
software and are as follows: IL-6: 5′-CACACAGACAGCCACTCACC-3′ and 5′-
TTTTCTGCCAGTGCCTCTTT-3′; β-actin: 5′-ACCGCGAGAAGATGACCCAG-3′ and 5′-
TTAATGTCACGCACGATTTCCC-3′. Human IL-6 expression in different HeLa stable cell
lines was also analyzed by RT-PCR. In this assay, and cDNA was prepared from the total RNA
isolated with TriZol Reagent, using SuperScript III Gene Expression Tools (Invitrogen)
according to the manufacturer’s protocol. PCR was performed on 1 μl aliquots from each cDNA
reaction, using human IL-6 and β-actin primer sets (IL-6, 30 cycles; β-actin, 20 cycles). The
PCR products were subjected to electrophoresis on a 2% agarose gel.
2.7. Generation of stable HeLa cells expressing shRNA targeting PPM1A or PPM1B
The pSuper-PPM1A or PPM1B retroviral construct was transfected into HEK 293T cells with
retrovirus packing vector Pegpam 3e and RDF vector using FuGene 6 transfection reagent.
Viral supernatants were collected after 48 and 72 hours. HeLa cells were incubated with virus-
containing medium in the presence of 4 mg/ml polybrene (Sigma Aldrich). Stable cell lines
were established after 5 days of puromycin (2 μg/ml) selection and knockdown of the target
gene was confirmed by Western blotting.
2.8. Preparation of nuclear and cytosolic fractions
Nuclear and cytosolic extracts were made as described [27]. In brief, cells were harvested in
ice-cold PBS (pH 7.4) and were pelleted by 500 ×g for 3 min and then lysed for 30 min on ice
in buffer B (10 mM HEPES buffer, pH 7.9, containing 0.1 mM EDTA, 10 mM KCl, 0.4% (v/
v) IGEPAL, 0.5 mM dithiothreitol (DTT), and 1 mM phenylmethylsulfonyl fluoride (PMSF)).
Cell lysates were centrifuged at 15,000×g for 15 min, 4°C. The resulting supernatants
constituted cytosolic fractions. The pellets were washed three times with buffer B and then
resuspended in buffer C (20 mM HEPES buffer, pH 7.9, containing 400 mM NaCl, 1 mM
EDTA, 1 mM DTT and 1 mM PMSF) and incubated for 30 min on ice, then centrifuged at
15,000×g for 15 min. The supernatants were used as nuclear extracts.
2.9. Immunoblotting and immunoprecipitation
Cells were harvested in ice-cold PBS (pH 7.4) and spun down. The pellets were dissolved in
lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% IGEPAL, 0.25% Na-
deoxycholate, 1 mM PMSF, 1 mM DTT, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM
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Benzamidine, 20 mM disodium p-nitrophenylphosphate (pNPP), 0.1 mM sodium
orthovanadate (OV), 10 mM sodium fluoride (NaF), phosphatase inhibitor cocktail A and B
(Sigma Aldrich)). The cell lysates were either subjected directly to 10% SDS-PAGE for
immunoblotting analysis or immunoprecipitated for 3 hrs with the indicated antibodies.
Immune complexes were recovered with protein A/G-agarose (Santa Cruz Biotechnology) for
3 hrs, then washed three times with wash buffer containing 20 mM HEPES (pH 7.4), 50 mM
NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, and 0.05% Triton X-100. For immunoblotting, the
immunoprecipitates or 10% whole cell lysates (WCL) were resolved on SDS-PAGE and
transferred to nitrocellulose membranes. The membranes were immunoblotted with various
antibodies, and the bound antibodies were visualized with horseradish peroxidase-conjugated
antibodies against rabbit or mouse IgG using the ECL-Plus Western blotting system (GE
Healthcare Biosciences Corp., USA) according to the manufacturer’s instruction.
2.10. Purification of GST-PPM1A and PPM1B fusion proteins
All the above-mentioned GST plasmids (GST-PPM1A-wt, GST-PPM1A-R174G, GST-
PPM1B-wt and GST-PPM1B-R179G) were transformed into E. coli BL-21 strain (Invitrogen),
and then the bacteria were grown in Luria broth at 37°C to an A600=0.6 before induction with
0.1 mM isopropyl β-d-thiogalactoside (IPTG) for 4 hrs at 30°C. Bacteria were pelleted and
lysed with extraction buffer (50 mM Tris–HCl, pH 8.5, 100 mM NaCl, 1 mM EDTA, 1 mM
DTT, 50 mg/ml lysozyme, 10 μg/ml aprotinin, 10 μg/ml leupeptin, and 1 mM PMSF) 45 min
on ice. The bacteria were sonicated at 4°C in 1% Sarcosyl (Sigma Aldrich), after which Triton
X-100 (1%), 5 μg/ml DNase, and 5 μg/ml RNase (Roche) were added. The lysates were
centrifuged at 15,000×g and the supernatants containing GST fusion proteins were collected.
Fusion proteins were purified from cell lysates using glutathione–sepharose beads (Sigma
Aldrich) overnight at 4°C. The beads were washed three times in extraction buffer containing
0.5% Triton X-100, one time in extraction buffer containing 0.1% Triton X-100. Proteins were
eluted in elution buffer (30.7% glutathione, 50 mM Tris-HCl, pH 8.0, 20% glycerol, 5M NaCl)
and dialyzed in PBS. The protein concentrations were then assessed with a Bradford Protein
Assay (Bio-Rad). The proteins were visualized by 10% SDS-PAGE and Coomassie blue
staining of the gel.
2.11. Phosphatase Assays
HEK 293T cells seeded onto 10 cm dishes were transfected with the HA-IKKβ expression
plasmid. The HA-IKKβ proteins were immunoprecipitated from cell extracts with anti-HA
antibody. After washing beads three times with the wash buffer, the immunoprecipitated HA-
IKKβ were then incubated with or without recombinant GST-PPM1A or GST-PPM1B
wildtype or phosphatase-deficient mutant proteins in phosphatase 2C buffer (250 mM
imidazole, pH 7.2, 1 mM EGTA, 25 mM MgCl2, 0.1% 2-mercaptoethanol, 10% BSA) or
Lambda Protein Phosphatase (λ-Ppase) at 30°C for 30 min. The phosphatase reactions were
then terminated by boiling in protein sample buffer and proteins were separated by 10% SDS-
PAGE. The levels of HA-IKKβ phosphorylation were measured by immunoblotting analysis
with antibody against phospho-IKKβ.
3. Results
3.1. PPM1A and PPM1B are IKKβ Phosphatases
Phosphorylation of Ser177 and Ser181 at the activation loop of IKKβ is essential for activation
of IKKβ by TNFα [18]. We hypothesized that the potential IKKβ phosphatase targeting these
two sites might be a member of protein serine/threonine phosphatase family. We then generated
a library of mammalian expression vectors that encode 23 protein serine/threonine
phosphatases (catalytic subunits if it is multimeric) including 11 PPPs and 12 PPMs. In order
to validate the expression of our phosphatase library, we also made a library of phosphatases
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with Myc tag and found that they all can be overexpressed once transfected in HEK-293T cells
(data not shown). However, to avoid the possibility that the fused Myc tag affects the
phosphatase function, we used the library of phosphatases without Myc tag in our screening.
Then we used an NF-κB luciferase reporter assay to assess the effect of overexpression of each
phosphatase on IKKβ-induced NF-κB activation. In this screen, as shown in Fig. 1A, both
PPM1A and PPM1B almost completely abolished IKKβ-induced NF-κB activation whereas
other phosphatases had either no or less effect. To validate our results from the screening assay,
we chose the phosphatases with some degree of inhibition on IKKβ-induced NF-κB activation
and examined the effects of overexpression of these phosphatases including PPM1A and
PPM1B on the phosphorylation status of Ser177 and Ser181 at the IKKβ kinase activation
loop. Consistent with our reporter screening assay, overexpression of both PPM1A and PPM1B
abolished the phosphorylation of IKKβ at Ser177 and Ser181 (Fig. 1B). To assess whether the
effects of PPM1A and PPM1B on IKKβ are due to their phosphatase activity, we generated
expression vectors encoding both PPM1A and PPM1B phosphatase-deficient Arg (R) to Gly
(G) mutants and found that only wildtype PPM1A and PPM1B, but not phosphatase-deficient
mutants, abolished the phosphorylation of Ser177 and Ser181 at the activation loop of IKKβ
(Fig. 1C) and the IKKβ-induced NF-κB activation (Fig. 1D). To further test the role of PPM1A
and PPM1B on NF-κB activation induced by wildtype- or S177E/S181E constitutively active
mutant-IKKβ. We found that both PPM1A and PPM1B were able to abolish the wildtype
IKKβ-induced NF-κB activation almost completely whereas they failed to terminate the NF-
κB activation induced by the IKKβ constitutively active mutant (Fig. 1E). PPM1B has actually
been reported to be involved in the regulation of TAK1 phosphorylation and activation [27].
To further determine whether PPM1A and PPM1B are able to dephosphorylate the activated
IKKβ directly, we examined the phosphorylation status of the phosphorylated IKKβ incubated
with purified recombinant GST-PPM1A and GST-PPM1B in vitro. In this assay, HA-IKKβ
was overexpressed in HEK 293T cells, and phosphorylated HA-IKKβ was immunoprecipitated
from cell extracts with anti-HA antibody and incubated with recombinant GST-PPM1A or
GST-PPM1B or their respective phosphatase-deficent mutants (R/G), or λ-PPase as a control.
The phosphorylation level of HA-IKKβ was found to be significantly decreased by co-
incubation with both GST-PPM1A and GST-PPM1B wildtype proteins, as well as with λ-
PPase, but not phosphatase-deficient mutant proteins (Fig. 1F). These results demonstrate that
PPM1A and PPM1B target on the phosphorylated Ser177 and Ser181 within the activation
loop of IKKβ. Taken together, our results strongly suggest that PPM1A and PPM1B are
IKKβ phosphatases and responsible for terminating IKKβ-mediated NF-κB activation.
3.2. PPM1A and PPM1B bind to the phosphorylated IKKβ
To assess whether IKKβ interacts with PPM1A and PPM1B, the expression vectors encoding
HA-tagged IKKβ were co-transfected with vectors encoding Myc-tagged PPM1A or PPM1B
wildtype or mutant PPM1A or PPM1B into HEK 293T cells. Then Myc-tagged PPM1A or
PPM1B wildtype or mutant proteins were immunoprecipitated from cell lysates with anti-Myc
antibody and immunoblotted with anti-HA antibody. Interestingly, only the mutant but not the
wildtype Myc-tagged PPM1A or PPM1B pulled down HA-tagged IKKβ (Fig. 2A). Consistent
with the above results, we found that the IKKβ with serine to alanine double mutation at Ser177
and Ser181 could not bind either wild-type or mutant PPM1A and PPM1B (data not shown).
These results suggest that only phosphorylated IKKβ binds to PPM1A and PPM1B as the
substrate for these two phosphatases. To further evaluate these bindings, the transfected cells
as described above were treated with TNFα for the time periods as indicated (Fig. 2B). The
Myc-tagged PPM1A and PPM1B in the cell lysates were immunoprecipitated with the antibody
against Myc epitope and immunoblotted with anti-HA antibody to detect the presence of HA-
tagged IKKβ. As shown in Fig. 2B, TNFα rapidly induced co-immunoprecipitation of IKKβ
and PPM1A or PPM1B within 5 min. These results suggest that TNFα-induced IKKβ
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phosphorylation and activation results in the binding of both PPM1A and PPM1B to the
phosphorylated IKKβ.
3.3. Suppression of PPM1A and PPM1B expression enhances TNFα-mediated NF-κB
activation
TNFα induces a strong NF-κB activation through the phosphorylation and activation of
IKKβ [2,18]. To further address the role of PPM1A and PPM1B in TNFα-induced IKKβ
phosphorylation and IKKβ-NF-κB activation, we generated short hairpin RNA (shRNA)
expression vectors for knocking down the expression of PPM1A and PPM1B and found that
PPM1A and PPM1B expression can be suppressed by these shRNA expression vectors (Fig.
3A). Subsequently we found that co-transfection of HA-IKKβ with sh-PPM1A and sh-PPM1B
expression vectors in HeLa cells resulted in a higher IKKβ-induced NF-κB activation in an
NF-κB-dependent luciferase reporter assay (Fig. 3B). We then generated PPM1A and PPM1B
stable knockdown HeLa cell lines using a retroviral transduction system and analyzed the effect
of both PPM1A and PPM1B knockdown on the TNFα-induced IKKβ phosphorylation and NF-
κB nuclear translocation. In this assay, HeLa cells with sh-control, sh-PPM1A and sh-PPM1B
stable expression were then treated with TNFα for the different time periods as indicated and
subsequently lysed (Fig. 3C and 3D). We found that knockdown of PPM1A and PPM1B
expression caused the enhanced phosphorylation of IKKβ at the early time points of TNFα
stimulation and sustained phosphorylation of IKKβ at the later time points of stimulation
(Figure 3C). Nuclear extracts from these cells treated at different time points were prepared
and immunoblotted with an antibody specific for NF-κB-p65. We found that knockdown of
PPM1A and PPM1B expression resulted in sustained NF-κB nuclear localization at the later
time points of stimulation (Figure 3D). Consistent with the above results, knockdown of
PPM1A and PPM1B expression in HeLa cells resulted in a higher TNFα-induced NF-κB
activation in an NF-κB-dependent luciferase reporter assay (Fig. 3E). Taken together, these
results demonstrate that PPM1A and PPM1B are responsible for terminating TNFα-induced
IKKβ phosphorylation and NF-κB nuclear translocation and activation in the cells.
3.4. PPM1A and PPM1B are required for the down-regulation of TNFα-induced NF-κB
dependent IL-6 gene expression
IKKβ is essential in TNFα-induced NF-κB activation and NF-κB-dependent IL-6 expression
[28]. To determine the role of PPM1A and PPM1B on the regulation of TNFα-induced IL-6
gene expression, total RNA was extracted from the control, PPM1A and PPM1B knockdown
HeLa cell lines treated with or without TNFα for 1 hr. Then RT-PCR was carried out to examine
the TNFα-induced IL-6 expression levels in the cells. As shown in Fig. 4A and 4B, TNFα
induced a much higher level of the IL-6 expression in the cells with PPM1A and PPM1B
knockdown compared to the control cells within 1 hr. These results suggest that PPM1A and
PPM1B negatively regulate TNFα-mediated gene expression through inhibiting the TNFα-
induced IKKβ phosphorylation and activation.
4. Discussion
IKKβ phosphorylation and activation is an essential step in TNFα-induced NF-κB activation
[2]. Phosphorylation of the conserved residues Ser177 and Ser181 within the kinase activation
loop is required for IKKβ activation [18]. Following TNFα stimulation, IKKβ is rapidly
phosphorylated at Ser177 and Ser181 residues and activated within 5 min. Then IKKβ will be
quickly inactivated by dephosphorylation at Ser177 and Ser181 residues suggesting that
stringent control of IKKβ phosphorylation and activity is critical for normal TNFα-mediated
cellular responses. However, the mechanism of IKKβ dephosphorylation and inactivation
following TNFα stimulation to attenuate TNFα-induced NF-κB activation has not been
completely defined.
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Although several phosphatases have been suggested to be involved in the regulation of
IKKβ activity [16,21–23], it is still not clear whether these phosphatases are truly IKKβ
phosphatases that downregulate IKKβ activity through the dephosphorylation of IKKβ at the
conserved residues Ser177 and Ser181 within the kinase activation loop. Therefore, we decided
to take a functional genomic approach to further analyze the mechanism of IKKβ inactivation
and identify IKKβ-specific phosphatase(s). In this study, we identify that PPM1A and PPM1B
are two major phosphatases involved in negatively regulating IKKβ phosphorylation and
activation. We demonstrate that PPM1A and PPM1B are essential to terminate IKKβ-mediated
NF-κB activation through binding to the activated form of IKKβ and dephosphorylating
IKKβ at the conserved residues Ser177 and Ser181. Our studies suggest that PPM1A and
PPM1B function as the IKKβ phosphatases and serve as an important Yin-Yang regulatory
mechanism to maintain a delicate balance in TNFα-mediated inflammatory responses.
In this investigation, we found that only PPM1A and PPM1B phosphatase-deficient mutants
but not the wildtype are able to pull down the phosphorylated IKKβ, as demonstrated by our
co-transfection and immunoprecipitation assays. These data suggest that PPM1A and PPM1B
only bind to the phosphorylated IKKβ. In addition, TNFα induces the interaction between
IKKβ and PPM1A/PPM1B in a temporary fashion. However, we could not show the TNFα-
induced endogenous IKKβ and PPM1A/PPM1B binding possibly due to lack of good
antibodies for immunopreciptation of PPM1A and PPM1B. Together, these results are
consistent with our prediction that TNFα-induced IKKβ activation is rapidly terminated by
IKKβ-phosphatases through physical interaction and dephosphorylation.
Prajapati et al. reported that PPM1B negatively regulate IKKβ kinase activity [21]. Consistent
with this early report, our studies demonstrate that PPM1B is one of IKKβ phosphatases;
meanwhile, we also found that PPM1A is another IKKβ phosphatase. Prajapati et al. reported
that PPM1B was within the IKK/NEMO complex [21]. However, we failed to observe a strong
association between dephosphorylated IKKβ and PPM1B. Instead, we found that the
association between IKKβ and PPM1B was transient and IKKβ-phosphorylation dependent.
This discrepancy may be explained by the possibility that IKKβ is partially phosphorylated at
Ser177 and Ser181 in the co-immunoprecipitation assays reported by Prajapati et al. In
addition, PPM1B was reported to be involved in the regulation of TAK1 phosphorylation and
activation. Purified recombinant PPM1A and PPM1B are able to dephosphorylate IKKβ at
Ser177 and Ser181 in vitro. This result suggests that phosphorylated IKKβ is a direct target
for PPM1A and PPM1B phosphatases. Due to the fact that TAK1 is an upstream activating
kinase for IKKβ, it is reasonable to speculate that PPM1B targets these two kinases to inactivate
TAK1-IKKβ dependent NF-κB activation. However, it is not clear whether PPM1A also targets
TAK1.
PPM1A and PPM1B proteins share 76% amino acid sequence identity [29,30]. Several kinases
have been identified to be the substrates for both PPM1A and/or PPM1B including AMPK,
CDK2, CDK6, JNKK1, p38 and TAK1 [29,31–34]. Interestingly, PPM1A inhibits TNFα-
induced JNK and p38 activation through dephosphorylation of MKK4/JNKK1 and MKK6 as
well as p38 [33]. These results suggest that PPM1A and PPM1B may act synergistically to
terminate TNFα-induced NF-κB and AP-1 activation in the cells. Interstingly, we observed a
strong effect of knockdown of PPM1A or PPM1B expression alone on TNFα-induced IKKβ
phosphorylation and activation. These results indicate these two phosphatases do not have a
completely functional overlap. Currently, little is known about the regulation of PPM1A and
PPM1B function. It is likely that these two phosphatases function in a complex to inactivate
IKKβ-mediated NF-κB activation. Further studies are needed to determine the mechanism of
PPM1A and PPM1B function in the negative regulation of TNFα-induced IKKβ activation.
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Our current studies demonstrate that both PPM1A and PPM1B are two IKKβ phosphatases.
However, we can not rule out the possibility that other phosphatases are also involved in
IKKβ dephosphorylation and inactivation. Further studies are needed to determine whether
other phosphatases are directly involved in the negative regulation of IKKβ activation.
In conclusion, our data provide evidence of the physical and functional interaction between
IKKβ and PPM1A and PPM1B. In view of the data presented here and in previous reports, we
propose a working model (Fig. 5), in which upon TNFα-induced IKKβ phosphorylation at
Ser177 and Ser181, PPM1A and PPM1B phosphatases would bind to the phosphorylated
IKKβ. This binding would be a requisite step for PPM1A and PPM1B-mediated
dephosphorylation and inactivation of IKKβ as well as the termination of the TNFα-induced
NF-κB activation. This report provides the first direct evidence that PPM1A and PPM1B
terminate TNFα-induced NF-κB activation through dephosphorylation of IKKβ at Ser177 and
Ser181 residues.
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Fig. 1. PPM1A and PPM1B are IKKβ phosphatases
(A) The effect of overexpression of members of serine/threonine phosphatases or the catalytic
subunit of polymeric phosphatases on the IKKβ-induced NF-κB activation. HA-IKKβ
expression plasmid, NF-κB luciferase reporter plasmid and Renilla luciferase plasmid were
co-transfected into HEK 293T cells with empty vector or different phosphatase expression
plasmids. The relative luciferase activity was measured 36 hrs later and normalized with the
Renilla activity. Error bars indicate ± standard deviation in triplicate experiments. (B) The
effect of overexpression of members of serine/threonine phosphatases or the catalytic subunit
of polymeric phosphatases on the IKKβ phosphorylation at Ser177 and Ser181 within the
kinase activation loop. Cell extracts were prepared from HEK 293T cells transfected with
expression vectors for HA-IKKβ and different expression vectors for phosphatases as
indicated, and analyzed by immunoblotting with the anti-phospho-IKKβ antibody (Ser177/
Ser181) (top panel) and reprobed with an anti-HA antibody to detect the expression level of
HA-IKKβ (bottom panel). (C) PPM1A and PPM1B phosphatase activities are required for their
effect on IKKβ phosphorylation at Ser177 and Ser181. Cell extracts were prepared from HEK
293T cells transfected with expression vectors for HA-IKKβ and Myc-tagged PPM1A/PPM1B
wildtype or phosphatase-deficient versions (R/G), and immunoprecipitated with the anti-HA
antibody, then immunoblotted with the anti-phospho-IKKβ antibody (top panel) and reprobed
with an anti-HA antibody to detect the expression level of HA-IKKβ (bottom panel). (D)
PPM1A and PPM1B phosphatase activities are required for their effect on IKKβ-induced NF-
κB activation. HA-IKKβ expression plasmid, NF-κB luciferase reporter plasmid and Renilla
luciferase plasmid were co-transfected into HEK 293T cells with empty vector or expression
vectors for both wildtype and mutants (R/G) of PPM1A and PPM1B. The relative luciferase
activity was measured 36 hrs later and normalized with the Renilla activity. Error bars indicate
± standard deviation in triplicate experiments. (E) IKKβ constitutively active mutant is resistant
to the downregulation of IKKβ-mediated NF-κB activation by PPM1A and PPM1B
phosphatase activities. Expression plasmid encoding HA-IKKβ wildtype or constitutively
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active (EE), along with NF-κB luciferase reporter and Renilla luciferase plasmid were co-
transfected into HEK 293 cells with empty vector or wildtype PPM1A and PPM1B expression
vectors. The relative luciferase activity was measured 36 hrs later and normalized with the
Renilla activity. Error bars indicate ± standard deviation in triplicate experiments. (F)
Recombinant PPM1A and PPM1B dephosphorylate IKKβ in vitro. HA-IKKβ expression
vector was transfected into HEK 293T cells and immunoprecipitated with the anti-HA
antibody, then treated with 200 μg/ml of wildtype or phosphatase-deficient versions of
recombinant GST-PPM1A or PPM1B, or λ-PPase for 30 min before being analyzed by
immunoblotting with the anti-phospho-IKKβ antibody and reprobed with an anti-HA antibody
to detect the protein level of HA-IKKβ. The λ–PPase was used as a positive control. The
recombinant GST-PPM1A and PPM1B proteins used in above assays were detected by
Coomassie Blue staining.
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Fig. 2. PPM1A and PPM1B target the phosphorylated IKKβ
(A) PPM1A and PPM1B phosphatase-deficient mutants bind to phosphorylated IKKβ. Cell
extracts were prepared from HEK 293T cells transfected with expression vectors for HA-
IKKβ and different expression vectors for Myc-tagged phosphatases as indicated, and
immunoprecipitated with the anti-Myc antibody, then immunoblotted with the anti-HA
antibody. Portions of the WCL were immunoblotted with the anti-HA and anti-Myc antibodies
to detect the expression levels of HA-IKKβ and Myc-PPM1A and PPM1B or mutants (R/G)
in the cells. (B) TNFα induces the association of IKKβ with PPM1A and PPM1B. Expression
vectors for HA-IKKβ and Myc-PPM1A or Myc-PPM1B were co-transfected into HeLa cells
for 36 hrs, and then cells were either untreated or treated with TNFα (10 ng/ml) for the time
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periods as indicated. Myc-PPM1A or Myc-PPM1B in the cell extracts were
immunoprecipitated with the anti-Myc antibody, then immunoblotted with the anti-HA
antibody to detect the presence of HA-IKKβ. The WCL were immunoblotted with the anti-HA
and anti-Myc antibodies to detect the expression levels of HA-IKKβ and Myc-PPM1A and
PPM1B in the cells.
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Figure 3. Knockdown of PPM1A and PPM1B expression enhances TNFα-mediated NF-κB
activation
(A) Generation of small hairpin RNA (shRNA) expression vectors against PPM1A and
PPM1B. Expression vectors for Myc-PPM1A or Myc-PPM1B were co-transfected with
shRNA expression vectors against PPM1A and PPM1B into HeLa cells for 48 hrs, and then
the cells were lysed and the cell lysates were immunoblotted with the anti-Myc antibody to
detect the knockdown effect of these shRNA vectors in the cells. (B) Knockdown of PPM1A
or PPM1B enhances the IKKβ-induced NF-κB activation. HA-IKKβ expression plasmid, NF-
κB luciferase reporter plasmid and Renilla luciferase plasmid were co-transfected into HeLa
cells with shRNA control vector or shRNA expression vectors for PPM1A and PPM1B. The
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relative luciferase activity was measured 48 hrs later and normalized with the Renilla activity.
Error bars indicate ± standard deviation in triplicate experiments. (C) Suppression of PPM1A
and PPM1B expression enhances the TNFα-induced IKKβ phosphorylation in the knockdown
cells. HeLa cells with stable expression of sh-control, sh-PPM1A or sh-PPM1B were either
untreated or treated with TNFα (10 ng/ml) for the time periods as indicated. Endogenous
IKKβ in the cell extracts were immunoblotted with the anti-phospho-IKKβ antibody to detect
the level of phospho-IKKβ induced by TNFα, and reprobed with an anti-IKKβ antibody to
detect the expression level of IKKβ in the cells. PPM1B and PPM1A knockdown effect by sh-
RNA expression were shown by the immunoblotting assay with anti-PPM1A and PPM1B
antibodies. β-actin was detected as a loading control. (D) Knockdown of PPM1A or PPM1B
expression enhances the TNFα-induced NF-κB nuclear translocation. The sh-control, sh-
PPM1A and sh-PPM1B Hela cell lines were either untreated or treated with TNFα (10 ng/ml)
for the time points as indicated and subsequently harvested. The nuclear extracts were prepared
and subjected to SDS-PAGE. Nuclear NF-κB-p65 was determined by immunoblotting with an
anti-p65 antibody, and PCNA was detected as a loading control. (E) Knockdown of PPM1A
or PPM1B expression enhances the TNFα-induced NF-κB activation. NF-κB luciferase
reporter plasmid and Renilla luciferase plasmid were co-transfected into HEK 293T cells with
sh-control, sh-PPM1A or sh-PPM1B expression plasmids for 30 hrs, and then the cells were
either untreated or treated with TNFα (1 ng/ml) for 6 hrs. The relative luciferase activity was
measured and normalized with the Renilla activity. Error bars indicate ± standard deviation in
triplicate experiments.
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Fig. 4. PPM1A and PPM1B negatively regulate TNFα-mediated IL-6 gene expression
(A) Knockdown of PPM1A or PPM1B expression enhances the TNFα-induced NF-κB
dependent IL-6 gene expression. The sh-control, sh-PPM1A and sh-PPM1B cell lines were
either untreated or treated with TNFα (1 ng/ml) for 1 hr. Total RNAs from these cells were
harvested. IL-6 transcript levels in the sh-control, sh-PPM1A and sh-PPM1B cell lines were
measured using quantitative RT-PCR normalized to GAPDH. The data is presented as the
average of three separate experiments with standard deviations. (B) One μg of above total RNA
was used to synthesize first-strand cDNA using a reverse transcription kit. The synthesized
cDNAs were used as templates for human IL-6 PCR amplification. β-actin PCR amplification
was used as a control. The PCR products were resolved in 2% agarose gel.
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Fig. 5. A working model for IKKβ dephosphorylation and inactivation mediated by PPM1A and
PPM1B
TNFα induces IKKβ phosphorylation and activation. PPM1A and PPM1B bind to the
phosphorylated IKKβ and subsequently dephosphorylate IKKβ at Ser177 and Ser181 to
terminate IKKβ-mediated NF-κB activation.
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